|
End-of-day quote
Johannesburg S.E.
2026-08-19
|
5-day change | 1st Jan Change | ||
| 141.88 ZAR | +0.95% |
|
-2.39% | +21.48% |
| 07-20 | Aspen Pharmacare wins Canada approval for generic Ozempic after Novo patent expiry | RE |
| 07-20 | Aspen Pharmacare wins Canada approval for generic Ozempic injection | RE |
| Market Cap | 63B 3.91B 3.35B 3.13B 2.87B 5.4B 374B 5.49B 36.96B 14.47B 187B 14.68B 14.36B 620B | P/E 2026 * |
14.4x | P/E 2027 * | 12.3x |
|---|---|---|---|---|---|
| Enterprise Value | 75.88B 4.71B 4.04B 3.77B 3.46B 6.51B 450B 6.62B 44.52B 17.43B 226B 17.68B 17.3B 746B | EV / Sales 2026 * |
2.02x | EV / Sales 2027 * | 1.58x |
| Free-Float |
59.64% | Yield 2026 * |
1.88% | Yield 2027 * | 1.77% |
Last Transcript: Aspen Pharmacare Holdings Limited
| 1 day | +0.95% | ||
| 1 week | -2.39% | ||
| Current month | -4.84% | ||
| 1 month | -5.61% | ||
| 3 months | +2.40% | ||
| 6 months | +12.06% | ||
| Current year | +21.48% |
| 1 week | 138 |  | 144.93 |
| 1 month | 138 | | 158.55 |
| Current year | 104.38 | | 160.79 |
| 1 year | 90.7 | | 160.79 |
| 3 years | 90.7 | | 252.96 |
| 5 years | 90.7 | | 281.67 |
| 10 years | 64.07 | | 367.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Saad
CEO | Chief Executive Officer | 62 | 1996-12-31 |
Sean Capazorio
DFI | Director of Finance/CFO | 61 | 2008-12-31 |
| Chief Operating Officer | 63 | 1998-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Saad
BRD | Director/Board Member | 62 | 1998-12-31 |
| Director/Board Member | 65 | 1998-12-31 | |
Kuseni Dlamini
CHM | Chairman | 58 | 2015-12-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 9/27/23 | Free | Chief Operating Officer | 12,236 | 0.0027% | ||
| 9/27/23 | Free | Executive/Senior Manager | 11,728 | 0.0026% | ||
| 9/27/23 | Free | Founder | 10,558 | 0.0024% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.95% | -2.39% | +26.24% | -24.83% | 3.84B | |
| +1.33% | -2.26% | +16.81% | +67.42% | 46.96B | |
| +4.02% | +0.68% | +55.08% | +131.77% | 39.63B | |
| -0.64% | -2.80% | -8.19% | +15.01% | 12.07B | |
| -0.99% | -8.34% | +11.63% | +70.49% | 11.61B | |
| 0.00% | +0.19% | +30.00% | +147.62% | 9.11B | |
| -0.39% | -1.15% | +19.93% | +39.54% | 7.47B | |
| +1.12% | +2.85% | +46.57% | -10.54% | 7.18B | |
| -2.54% | -1.90% | +15.45% | +193.20% | 6.79B | |
| -3.28% | -4.68% | -33.43% | +20.83% | 5.75B | |
| Average | -0.06% | -2.18% | +18.01% | +65.05% | 15.04B | |
| Weighted average by Cap. | +1.12% | -3.03% | +25.12% | +81.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.62B 2.34B 2B 1.87B 1.72B 3.23B 223B 3.28B 22.07B 8.64B 112B 8.77B 8.58B 370B | 38.86B 2.41B 2.07B 1.93B 1.77B 3.33B 231B 3.39B 22.8B 8.93B 116B 9.06B 8.86B 382B |
| Net income | 4.8B 298M 255M 239M 219M 412M 28.47B 418M 2.81B 1.1B 14.28B 1.12B 1.09B 47.2B | 5B 310M 266M 248M 228M 429M 29.64B 436M 2.93B 1.15B 14.86B 1.16B 1.14B 49.15B |
| Net Debt | 12.88B 799M 686M 640M 587M 1.1B 76.4B 1.12B 7.56B 2.96B 38.32B 3B 2.94B 127B | -1.74B -108M -92.39M -86.27M -79.16M -149M -10.3B -151M -1.02B -399M -5.16B -404M -396M -17.07B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-19 | ZAR 141.88 | +0.95% | 2,706,198 |
| 26-08-18 | ZAR 140.55 | -0.98% | 3,249,353 |
| 26-08-17 | ZAR 141.94 | -1.21% | 969,449 |
| 26-08-14 | ZAR 143.68 | +0.24% | 1,674,274 |
| 26-08-13 | ZAR 143.33 | -1.39% | 2,304,506 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- APN Stock
Select your edition
All financial news and data tailored to specific country editions
